DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
August 29, 2017

The Annual Long Range Planning meeting has been canceled due to potential inclement weather from hurricane Irma. We will reschedule the meeting for October. More information will follow. Continue reading


The eNLC Will Be Implemented on January 19, 2018
August 17, 2017

Florida RNs and LPNs will be able to start applying on January 19th to convert to a multi-state license. Continue reading